Masayuki Shibasaki Selected Research

Masayuki Shibasaki Research Topics

Disease

21	Type 2 Diabetes Mellitus (MODY) 03/2014 - 11/2006
8	Hyperglycemia 03/2014 - 03/2003
8	Glucose Intolerance 09/2013 - 07/2002
8	Hypertrophy 01/2012 - 01/2006
7	Insulin Resistance 09/2013 - 06/2006
6	Neoplasms (Cancer) 10/2020 - 11/2005
5	Hypoglycemia (Reactive Hypoglycemia) 04/2012 - 05/2008
5	Hyperplasia 01/2012 - 01/2006
4	Body Weight (Weight, Body) 03/2014 - 07/2002
4	Obesity 09/2013 - 06/2006
3	Inflammation (Inflammations) 07/2014 - 06/2010
3	Diabetic Nephropathies (Diabetic Nephropathy) 04/2011 - 11/2006
2	Neoplasm Metastasis (Metastasis) 10/2020 - 06/2015
2	Hemorrhage 01/2017 - 11/2005
2	Albuminuria 07/2014 - 11/2006
2	Hyperlipidemias (Hyperlipidemia) 09/2013 - 11/2006
2	Prostatic Neoplasms (Prostate Cancer) 11/2005 - 11/2005
1	Abdominal Pain (Pain, Abdominal) 01/2017
1	Splenomegaly 01/2017
1	Pathologic Constriction (Stenosis) 01/2016
1	Brain Neoplasms (Brain Tumor) 06/2015
1	Breast Neoplasms (Breast Cancer) 06/2015
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 07/2014
1	Weight Loss (Weight Reduction) 03/2014
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2013
1	Hyperinsulinism (Hyperinsulinemia) 09/2013
1	Pain (Aches) 04/2011
1	Wounds and Injuries (Trauma) 04/2011
1	Hypersensitivity (Allergy) 04/2011
1	Inappropriate ADH Syndrome (SIADH) 01/2011
1	Hypertriglyceridemia 10/2010
1	Cholestasis 06/2010
1	Neuralgia (Stump Neuralgia) 06/2010
1	Hyperalgesia 06/2010

Drug/Important Bio-Agent (IBA)

12	Glucose (Dextrose)FDA LinkGeneric 09/2013 - 07/2002
9	Hypoglycemic Agents (Hypoglycemics)IBA 04/2012 - 08/2006
9	Vasopressins (Vasopressin)IBA 01/2012 - 01/2006
8	Insulin (Novolin)FDA Link 09/2013 - 08/2006
6	Streptozocin (Streptozotocin)FDA Link 07/2014 - 12/2008
5	ipragliflozinIBA 07/2014 - 01/2012
5	Niacinamide (Nicotinamide)FDA LinkGeneric 09/2013 - 12/2008
5	4- fluoro- 1- (((4- methyl- 1- (methylsulfonyl)piperidin- 4- yl)amino)acetyl)pyrrolidine- 2- carbonitrileIBA 03/2009 - 05/2008
4	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2014 - 07/2008
4	YM 440IBA 11/2006 - 07/2002
3	Sodium-Glucose Transport ProteinsIBA 07/2014 - 01/2012
3	Blood Glucose (Blood Sugar)IBA 09/2013 - 02/2009
3	Collagen Type IV (Type IV Collagen)IBA 01/2012 - 02/2008
3	4'- (4,4- difluoro- 5- (2- oxo- 2- (4- piperidinopiperidino)ethylidene)- 2,3,4,5- tetrahydro- 1H- 1- benzoazepine- 1- carbonyl)- 2- methyl- 3- furanilideIBA 06/2007 - 01/2006
2	Hormones (Hormone)IBA 06/2015 - 04/2011
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 02/2013 - 10/2010
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2011 - 03/2011
2	Triglycerides (Triacylglycerol)IBA 10/2010 - 02/2009
2	Biological ProductsIBA 06/2010 - 11/2005
2	EnzymesIBA 05/2008 - 04/2008
2	ImmunosorbentsIBA 05/2008 - 04/2008
2	LigandsIBA 06/2006 - 11/2005
2	PPAR gammaIBA 06/2006 - 03/2003
2	Paclitaxel (Taxol)FDA LinkGeneric 03/2006 - 11/2005
2	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 03/2006 - 11/2005
2	Proteins (Proteins, Gene)FDA Link 01/2006 - 11/2005
2	Androgen Receptors (Androgen Receptor)IBA 11/2005 - 11/2005
2	AndrogensIBA 11/2005 - 11/2005
1	Cetuximab (Erbitux)FDA Link 10/2020
1	Capecitabine (Xeloda)FDA Link 06/2015
1	Lapatinib (GW572016)FDA Link 06/2015
1	Therapeutic UsesIBA 09/2013
1	bis(2- ((4- ((4'- (2- hydroxyethoxy)- 2'- methyl(1,1'- biphenyl)- 3- yl)methoxy)phenyl)methyl)- 3,5- dioxo- 1,2,4- oxadiazolidine)IBA 09/2013
1	Leucine (L-Leucine)FDA Link 01/2012
1	ThymidineIBA 01/2012
1	IGF Type 1 Receptor (IGF 1 Receptor)IBA 04/2011
1	Insulin-Like Growth Factor I (IGF-1)IBA 04/2011
1	Insulin-Like PeptidesIBA 04/2011
1	Sitagliptin Phosphate (Januvia)FDA Link 03/2011
1	Rosiglitazone (Avandia)FDA Link 03/2011
1	SecretagoguesIBA 03/2011
1	2- (4- bromophenyl)- 6- methyl- N- (2- (1- oxidopyridin- 3- yl)ethyl)pyrimidin- 4- amineIBA 11/2010
1	Glyburide (Glibenclamide)FDA LinkGeneric 11/2010
1	2- cyclopentyl- N- (2,4- dichloro- 3- ((isoquinolin- 5- yloxy)methyl)phenyl)- N- methylacetamideIBA 10/2010
1	AS 1907417IBA 10/2010
1	2- (2- (4- bromophenyl)- 6- methylpyrimidin- 4- yl)aminoethanolIBA 09/2010
1	HMGB ProteinsIBA 06/2010
1	CytokinesIBA 06/2010
1	Neutralizing AntibodiesIBA 06/2010
1	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 02/2009
1	Fatty Acids (Saturated Fatty Acids)IBA 02/2009
1	LipidsIBA 02/2009
1	CholesterolIBA 02/2009
1	Hemoglobin AIBA 02/2009
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2009
1	Dipeptidyl-Peptidases and Tripeptidyl-PeptidasesIBA 01/2009
1	Gastrointestinal Hormones (Hormones, Gastrointestinal)IBA 01/2009

Therapy/Procedure

6	Therapeutics 06/2015 - 11/2005
2	Anesthesia 01/2016 - 11/2005
2	Oral Administration 08/2013 - 03/2006
1	Induction Chemotherapy 10/2020
1	Splenectomy 01/2017
1	Tracheostomy 01/2016
1	CAP protocol 2 06/2015
1	Hepatectomy 06/2010
1	Glycemic Control 03/2009